MOP Posted July 17, 2009 Share Posted July 17, 2009 Novartis Says Swine Flu Virus Gives Poor Harvest for VaccineJuly 17 (Bloomberg) -- Novartis AG said the virus it’s growing to make a vaccine against pandemic flu doesn’t yield much of the antigen needed to protect people. Lab workers are harvesting one dose or less of the component they need from each egg in which the virus is grown, said Eric Althoff, a spokesman for the Swiss drugmaker. That’s between a third and half of the typical yield for a seasonal flu vaccine, he said. http://www.bloomberg.com/apps/news?pid=206...d=aaG4VHxwK.Oo# Link to comment Share on other sites More sharing options...
slurms mackenzie Posted July 17, 2009 Share Posted July 17, 2009 evolution. Link to comment Share on other sites More sharing options...
Johnny Storm Posted July 17, 2009 Share Posted July 17, 2009 If they make it seem rare more people will want it. Link to comment Share on other sites More sharing options...
bugged bunny Posted July 17, 2009 Share Posted July 17, 2009 If they make it seem rare more people will want it. Oh yes. And the implication for the evolving epidemic is that swine flu has a lot of catching up to do with seasonal flu regarding speed of replication. Any mutations that stabilise the haemagglutanin protein of swine flu (which will not be difficult to achieve thro' recombination and reassortment) will increase the viability of its progeny, and hence its virulence. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.